Taoyuan County, Taiwan

Chao-Cheng Chen


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Chao-Cheng Chen in Pharmaceutical Composition

Introduction

Chao-Cheng Chen is a notable inventor based in Taoyuan County, Taiwan. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of radiolabeled active targeting therapies. With a total of 2 patents, his work focuses on enhancing the effectiveness of treatments for tumors.

Latest Patents

One of Chao-Cheng Chen's latest patents is titled "Radiolabeled Active Targeting Pharmaceutical Composition and the Use Thereof." This invention involves a radiolabeled active targeting pharmaceutical composition that includes a bioconjugate and a radionuclide. The bioconjugate consists of a biomolecule and a metal nanoparticle, where the biomolecule has an affinity for receptors on the surface of a cell membrane. The biomolecule is selected from a group consisting of peptides and proteins. This invention also provides a method for evaluating thermal adjuvant therapy for tumors and includes a kit for this purpose. The pharmaceutical composition is designed to evaluate tumor accumulation time, which helps establish the optimal policy for radiofrequency- or laser-induced thermal adjuvant therapy for tumors.

Career Highlights

Chao-Cheng Chen has worked with esteemed organizations such as the Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, and National Yang Ming Chiao Tung University. His experience in these institutions has allowed him to develop innovative solutions in the field of nuclear energy and pharmaceuticals.

Collaborations

Chao-Cheng Chen has collaborated with notable colleagues, including Hsin-Ell Wang and Chien-Chung Hsia. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Chao-Cheng Chen's work in the development of radiolabeled active targeting pharmaceutical compositions showcases his innovative spirit and dedication to improving cancer therapies. His contributions are significant in the ongoing quest for effective treatments for tumors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…